Pharmaceutical Analytical Testing Outsourcing Market Research Report - Forecast till 2027

Pharmaceutical Analytical Testing Outsourcing Market Information: by Product Type (Raw Materials, API, Others), by Service (Bioanalytical Testing, Stability Testing, Others), by End User (Pharma Companies, Others), & by Region- Forecast till 2027

ID: MRFR/HC/5722-CR | April 2019 | Region: Global | 117 pages

Pharmaceutical Analytical Testing Outsourcing Market Overview


It is predicted that the Pharmaceutical Analytical Testing Outsourcing Market will register a CAGR growth of CAGR 8.6% and will reach USD 8095 million up to 2023. The pharmaceutical analytical market plays a significant role in the development of drugs and its manufacturing process. Pharmaceutical Analytical Testing provides information about the quality of raw materials, finished products, and their safety.


 According to Market Research Report - Global Forecast till 2023, due to the rapid growth of the pharmaceutical industry, the rise in demand for analytical information on drug and their process development done by regulatory agencies are the leading causes of the Pharmaceutical Analytical Testing Outsourcing Market in the past few years.


Extensive research, improvement in accessibility, initiatives by the government, and growing awareness lead to the Market.  Pharmaceutical companies are focusing and investing their money in Research and Development to develop sustainable drugs. However, not many companies have extensive infrastructure which is suitable for all kinds of analytical testing.


The government and companies collaborate to fulfill the gap between demand and supply in the Pharmaceutical Analytical Testing Outsourcing Market. It is predicted that the consumption of drugs will have a significant rise during the forecast period.

Global Pharmaceutical Analytical Testing Outsourcing Market Revenue, by Product Type, 2017 (USD Million)


Global Pharmaceutical Analytical Testing Outsourcing Market Revenue, by Product Type, 2017


COVID -19 Analysis of Pharmaceutical Analytical Testing Outsourcing Market


The COVID-19 pandemic had a massive negative impact on various industries in different sectors. There was an enormous demand for extensive research and new drugs to fight against the highly contagious virus. The global Pharmaceutical Analytical Testing Outsourcing Market had exponential growth due to increasing demand for food quality safety. Companies around the world collaborated worldwide for the production of efficient drugs and distributed them around various countries.


Market Dynamics


Market Drivers


As per Pharmaceutical Analytical Testing Outsourcing Market Research Report - Global Forecast till 2023, the increase in therapeutics and pharmaceuticals needs specialized manufacturing of products, which can help the market grow. The regulatory agencies are introducing stringent rules and regulations to maintain the standards and focusing on analytical details for production.


In Market, the companies focus on customized care, affecting the lifecycle of products. Due to this reason, the market is observing a rapid growth in innovation and development of new products. Also, the invention of compound products called biosimilars led to an increase in different types of tests. Also, outsourcing services has emerged as a suitable option among various pharmaceuticals companies. The pharmaceutical companies are focusing on enhancing the products; technological advancements and innovations are expected to influence the Pharmaceutical Analytical Testing Outsourcing Market.


Restraints


The global Pharmaceutical Analytical Testing Outsourcing Market is fragmented into various segments. One of the major market restraints is the dependence upon manufacturing organizations' performance, which may hinder the growth of the market. Another possible restraint is the privacy concerns, or data loss of the manufacturing pharmaceutical companies is also expected to hamper the market's development.


Opportunities


Many pharmaceutical companies are depended upon analytical testing to enhance productivity and monitor the whole process. The outsourcing of analytical testing allows various companies to handle complicated activities and focus upon main competencies.


The Global Market is expected to grow faster during the forecast period. The outsourcing of active pharmaceutical ingredients will reduce the investment in containment infrastructure, which is highly expensive. Also, various pharmaceutical companies provide expertise in pharmacology and in-house toxicology.


Cumulative Growth Analysis


The global Pharmaceutical Analytical Testing Outsourcing Market is growing steadily. The factors behind the growth are the rules and regulations set by governments around the world, improvement in the quality and safety of products, and patients' safety. It is estimated that the Market will grow at an 8.6% CAGR with USD 2095 million by the year 2023.


Value Chain Analysis


According to the Pharmaceutical Analytical Testing Outsourcing Market Research Report - Global Forecast till 2023, the outsourcing market will have a growth of 8.6%CAGR and gain USD 8095 million by 2023. The increasing investment in research and development is a crucial strategy. It will help companies around the world with the low capability to manufacture efficient products.


Pharmaceutical Analytical Testing Outsourcing Market Segment Overview


In Market Research Report - Global Forecast till 2023, the global Market is divided into product type, services, and end-user.


By Product



  • Finished Products

  • Active Pharmaceutical ingredients


By Services



  • Bioanalytical testing

  • Stability testing,

  • Method development & validation, 

  • And others


By End-User



  • Biopharmaceutical companies

  • Biotechnology industry.

  • Pharmaceutical 


Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market Share, 2017 (%)


Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market Share, 2017




Regional Analysis


As per Pharmaceutical Analytical Testing Outsourcing Market Research Report - Global Forecast till 2023, the North American region has dominated the Market. It is anticipated to hold the largest market share due to the increasing rampancy of chronic disease and rapid growth of contract research organizations (CRO). It is a hub of top manufacturing companies that manufacture high-end, reliable, and complex pharmaceuticals. The gradual rise in the production of drugs to fulfill the demand in this region is one of the prominent factors influencing the market growth.


Asia-Pacific is the second-largest region which has recorded the highest growth in the Pharmaceutical Analytical Testing Outsourcing Market. The pharmaceutical companies are focusing on investing in this region because of its low cost in development, capability to perform complex tasks, and GMP compliance growth. Also, the bulk manufacturers are available in developing countries like India, and China has pushed the market.


The European market has shown significant growth in Pharmaceutical Analytical Testing Outsourcing Market due to increased government funding to help the industry for research and development to avoid chronic diseases, improve the expenditure in the healthcare facilities, and develop pharmaceutical sectors.


It is estimated that the Middle East and African region will have the lowest growth due to lack of awareness, funds, proper healthcare facilities, and low per capita income.


Competitive Landscape of Pharmaceutical Analytical Testing Outsourcing Market


Several market players have dominated Pharmaceutical Analytical Testing Outsourcing Market by using several strategies like launching new products, business expansions, joint ventures, agreements, acquisitions, partnerships, etc., to boost their revenue and growth of their portfolio. Some of the leading market players include Boston Analytical (New Hampshire), Merck KGaA (Germany), West Pharmaceutical Services, Inc. (U.S.), Exova Group PLC (U.K.), Source BioScience (U.K.), etc. These companies are predicted to dominate the global market and generate good revenue in the upcoming years.


In the year 2019, August, Boston Analytical had opened a new office situated in Cambridge to expand its business.


Here is the list of competitive companies in the Pharmaceutical Analytical Testing Outsourcing Market-



  • Boston Analytical (New Hampshire)

  • West Pharmaceutical Services, Inc. (U.S.)

  • Exova Group PLC (U.K.)

  • Source BioScience (U.K.)

  • Pace Analytical Services, Inc. (U.S.)

  • Merck KGaA (Germany), WuXi AppTec (US)

  • Toxikon (US), Eurofins Scientific (Belgium)

  • Intertek Group Plc (U.K.)

  • Eurofins Scientific (Luxembourg)

  • West Pharmaceutical Services Inc. (U.S.)

  • Charles River Laboratories International, Inc (U.S.)

  • SGS SA (U.K.)

  • Pharmaceutical Product Development, LLC (U.S.)

  • Source BioScience (U.K.)

  • WuXi AppTec (U.S.)


Recent Developments


The key market players have applied various Pharmaceutical Analytical Testing Outsourcing Market strategies such as mergers, acquisitions, development of the product, innovation of new products, etc.


Cambrex Corporation, in 2018, announced that it had acquired Halo Pharma. This step will help to strengthen Cambrex's position in the Pharmaceutical Analytical Testing Outsourcing Market. The acquisition will help to provide biotechnological and pharmaceutical organizations with the development and manufacturing services.


In the year 2019 April, Charles River Laboratories International, Inc. announced its acquisition of Citoxlab. The acquisition will help Charles River expand its business due to the expertise of Citoxlab in providing services of CRO (Contract Research Organisation) to the countries in the European and North American region.  This is a crucial step taken by Charles Rives to expand business in Charles River Laboratories International, Inc.


STA Pharmaceutical Co. Ltd. announced its agreement for investment with the government of Shanghai in Jinshan District to build a new Research and Development center. The new investment will help to strengthen WuXiA STA’s development in manufacturing and development of pharmaceuticals.


Report Overview and Segmentation


By Service



  • Stability Testing

  • Bioanalytical Testing

  • Method Development & Validatio


By Product



  • Finished Products

  • Raw Materials

  • Active Pharmaceutical Ingredients


By End-User



  • Biotechnology Industry

  • Pharmaceutical and Biopharmaceutical Companies


By Region



  • Europe (Germany, France, Spain, Italy, U.K.)

  • North America (The U.S. and Canada)

  • Asia Pacific (India, Japan, China, Australia, and rest)

  • Latin America (Mexico, Brazil, and rest)

  • The Middle East and Africa (GCC, South Africa, and others)



Report Scope:
Report Attribute/Metric Details
  Market Size   2023: USD 8095 million
  CAGR   2019-2023: 8.6%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Services, and End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Boston Analytical (New Hampshire), Merck KGaA (Germany), West Pharmaceutical Services, Inc. (U.S.), Exova Group PLC (U.K.), Source BioScience (U.K.), etc
  Key Market Opportunities   Innovation And Launch Of New Tests To Check The Quality Of Products
  Key Market Drivers

  • Growing Pharmaceutical Industry
  • Increasing Demand For Analytical Details On Drugs And Process Development By Regulatory Agencies
  • Growing Prevalence Of Cancer And Infectious Diseases


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Market Research Future States that Global Pharmaceutical Analytical Testing Outsourcing Market is estimated to reach USD 8,095 Million by 2023

    Exova Group PLC (UK), Boston Analytical (New Hampshire), Charles River Laboratories International, Inc (US), West Pharmaceutical Services, Inc. (US)

    Global Pharmaceutical Analytical Testing Outsourcing Market is expected to register a CAGR of 8.6% during forecast period upto 2027

    Pharmaceutical Analytical Testing Outsourcing Market is driven by Increasing research and development in the pharmaceutical and biotechnology industry for the development of better treatment options for various chronic disease like cancer, diabetes, etc.

    The Americas is expected to hold the largest share of the global pharmaceutical analytical testing outsourcing market

    1 Executive Summary

    2 Market Introduction

    2.1 Scope of Study 15

    2.2 Research Objective 15

    2.3 List of Assumptions 16

    3 Research Methodology

    3.1 Research Process 17

    3.2 Primary Research 18

    3.3 Secondary Research 19

    3.4 Market Size Estimation 20

    4 Market Dynamics

    4.1 Introduction 21

    4.2 Drivers 22

    4.2.1 Growing Pharmaceutical Industry 22

    4.2.2 Increasing Demand for Analytical Details on Drugs and Process Development by Regulatory Agencies 22

    4.2.3 Growing Prevalence of Cancer and Infectious Diseases 22

    4.3 Restraints 23

    4.3.1 High Cost of Drug Discovery 23

    4.3.2 Inconsistency in the Quality of Products 23

    4.4 Opportunity 23

    4.4.1 Innovation and Launch of New Tests to Check the Quality of Products 23

    5 Market Factor Analysis

    5.1 Porter’s Five Forces Model 24

    5.1.1 Bargaining Power of Suppliers 24

    5.1.2 Bargaining Power of Buyers 25

    5.1.3 Threat of New Entrants 25

    5.1.4 Threat of Substitutes 25

    5.1.5 Intensity of Rivalry 25

    5.2 Value Chain Analysis 26

    5.2.1 Drug Discovery/Research 26

    5.2.2 Clinical and Preclinical Trials 26

    5.2.3 Manufacturing 27

    5.2.4 Sales and Distribution 27

    6 Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    6.1 Introduction 28

    6.2 Raw Materials 30

    6.3 Finished Products 30

    6.4 Active Pharmaceutical Ingredients 31

    7 Pharmaceutical Analytical Testing Outsourcing Market, By Services

    7.1 Introduction 32

    7.2 Bioanalytical Testing 34

    7.3 Method Development & Validation 34

    7.4 Stability Testing 35

    8 Pharmaceutical Analytical Testing Outsourcing Market, By End User

    8.1 Introduction 36

    8.2 Pharmaceutical and Biopharmaceutical Companies 38

    8.3 Biotechnology industry 38

    9 Global Pharmaceutical Analytical Testing Outsourcing Market, By Region

    9.1 Introduction 39

    9.2 Americas 42

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.2.1 North America 44

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.2.1.1 US 47

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.2.1.2 Canada 48

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.2.2 South America 50

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.3 Europe 52

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.3.1 Western Europe 54

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.3.1.1 Germany 57

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.3.1.2 UK 58

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.3.1.3 France 60

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.3.1.4 Italy 61

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.3.1.5 Spain 63

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.3.1.6 Rest of Western Europe 64

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.3.2 Eastern Europe 66

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.4 Asia Pacific 68

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.4.1 Japan 70

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.4.2 China 72

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.4.3 India 73

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.4.4 Australia 75

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.4.5 South Korea 76

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.4.6 Rest of Asia-Pacific 78

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.5 Middle East & Africa 80

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.5.1 Middle East 82

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    9.5.2 Africa 84

    Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

    Pharmaceutical Analytical Testing Outsourcing Market, By Services

    Pharmaceutical Analytical Testing Outsourcing Market, By End User

    10 Competitive Landscape

    10.1 Competitive Landscape 86

    11 Company Profiles

    11.1 Exova Group PLC 87

    11.1.1 Company Overview 87

    11.1.2 Financial Overview 87

    11.1.3 Products/Services Offered 87

    11.1.4 Key Developments 87

    11.1.5 SWOT Analysis 88

    11.1.6 Key Strategies 88

    11.2 Boston Analytical 89

    11.2.1 Company Overview 89

    11.2.2 Financial Overview 89

    11.2.3 Products/Services Offered 89

    11.2.4 Key Developments 90

    11.2.5 SWOT Analysis 90

    11.2.6 Key Strategies 90

    11.3 Charles River Laboratories International, Inc 91

    11.3.1 Company Overview 91

    11.3.2 Financial Overview 91

    11.3.3 Products/Services Offered 92

    11.3.4 Key Developments 92

    11.3.5 SWOT Analysis 92

    11.3.6 Key Strategies 92

    11.4 West Pharmaceutical Services, Inc. 93

    11.4.1 Company Overview 93

    11.4.2 Financial Overview 93

    11.4.3 Products/Services Offered 93

    11.4.4 Key Developments 94

    11.4.5 SWOT Analysis 94

    11.4.6 Key Strategies 94

    11.5 Merck KGaA 95

    11.5.1 Company Overview 95

    11.5.2 Financial Overview 95

    11.5.3 Products/Services Offered 96

    11.5.4 Key Developments 96

    11.5.5 SWOT Analysis 96

    11.5.6 Key Strategies 96

    11.6 WuXi AppTec 97

    11.6.1 Company Overview 97

    11.6.2 Financial Overview 97

    11.6.3 Products/Services Offered 97

    11.6.4 Key Developments 98

    11.6.5 SWOT Analysis 98

    11.6.6 Key Strategies 98

    11.7 Source BioScience 99

    11.7.1 Company Overview 99

    11.7.2 Financial Overview 99

    11.7.3 Products/Services Offered 99

    11.7.4 Key Developments 99

    11.7.5 SWOT Analysis 100

    11.7.6 Key Strategies 100

    11.8 SGS SA 101

    11.8.1 Company Overview 101

    11.8.2 Financial Overview 101

    11.8.3 Products/Services Offered 102

    11.8.4 Key Developments 103

    11.8.5 SWOT Analysis 103

    11.8.6 Key Strategies 103

    11.9 Toxikon 104

    11.9.1 Company Overview 104

    11.9.2 Financial Overview 104

    11.9.3 Products/Services Offered 104

    11.9.4 Key Developments 104

    11.9.5 SWOT Analysis 105

    11.9.6 Key Strategies 105

    11.10 Eurofins Scientific 106

    11.10.1 Company Overview 106

    11.10.2 Financial Overview 106

    11.10.3 Products/Services Offered 107

    11.10.4 Key Developments 107

    11.10.5 SWOT Analysis 108

    11.10.6 Key Strategies 108

    11.11 Pace Analytical Services, LLC 109

    11.11.1 Company Overview 109

    11.11.2 Financial Overview 109

    11.11.3 Products/Services Offered 109

    11.11.4 Key Developments 110

    11.11.5 SWOT Analysis 110

    11.11.6 Key Strategies 110

    11.12 Intertek Group PLC 111

    11.12.1 Company Overview 111

    11.12.2 Financial Overview 111

    11.12.3 Products/Services Offered 112

    11.12.4 Key Developments 112

    11.12.5 SWOT Analysis 112

    11.12.6 Key Strategies 112

    11.13 Pharmaceutical Product Development, LLC 113

    11.13.1 Company Overview 113

    11.13.2 Financial Overview 113

    11.13.3 Products/Services Offered 113

    11.13.4 Key Developments 113

    11.13.5 SWOT Analysis 114

    11.13.6 Key Strategies 114

    12 Appendix

    12.1 References 115

    12.2 Related Reports 115

    13 List of Tables

    TABLE 1 LIST OF ASSUMPTIONS 16

    TABLE 2 PRIMARY INTERVIEWS 18

    TABLE 3 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 29

    TABLE 4 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR RAW MATERIALS, BY REGION, 2020 TO 2027 (USD MILLION) 30

    TABLE 5 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR FINISHED PRODUCTS, BY REGION, 2020 TO 2027 (USD MILLION) 30

    TABLE 6 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2020 TO 2027 (USD MILLION) 31

    TABLE 7 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 33

    TABLE 8 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR BIOANALYTICAL TESTING, BY REGION, 2020 TO 2027 (USD MILLION) 34

    TABLE 9 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR METHOD DEVELOPMENT & VALIDATION, BY REGION, 2020 TO 2027 (USD MILLION) 34

    TABLE 10 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR STABILITY TESTING, BY REGION, 2020 TO 2027 (USD MILLION) 35

    TABLE 11 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 37

    TABLE 12 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020 TO 2027 (USD MILLION) 38

    TABLE 13 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR BIOTECHNOLOGY INDUSTRY, BY REGION, 2020 TO 2027 (USD MILLION) 38

    TABLE 14 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 41

    TABLE 15 AMERICAS: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 42

    TABLE 16 AMERICAS: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 43

    TABLE 17 AMERICAS: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 43

    TABLE 18 AMERICAS: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 44

    TABLE 19 NORTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY COUNTRY, 2020 TO 2027 (USD MILLION) 44

    TABLE 20 NORTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 45

    TABLE 21 NORTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 46

    TABLE 22 NORTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 46

    TABLE 23 US: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 47

    TABLE 24 US: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 47

    TABLE 25 US: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 48

    TABLE 26 CANADA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 48

    TABLE 27 CANADA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 49

    TABLE 28 CANADA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 49

    TABLE 29 SOUTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 50

    TABLE 30 SOUTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 50

    TABLE 31 SOUTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 51

    TABLE 32 EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 52

    TABLE 33 EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 53

    TABLE 34 EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 53

    TABLE 35 EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 54

    TABLE 36 WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY COUNTRY/REGION, 2020 TO 2027 (USD MILLION) 54

    TABLE 37 WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 55

    TABLE 38 WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 56

    TABLE 39 WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 56

    TABLE 40 GERMANY: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 57

    TABLE 41 GERMANY: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 57

    TABLE 42 GERMANY: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 58

    TABLE 43 UK: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 58

    TABLE 44 UK: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 59

    TABLE 45 UK: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 59

    TABLE 46 FRANCE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 60

    TABLE 47 FRANCE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 60

    TABLE 48 FRANCE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 61

    TABLE 49 ITALY: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 61

    TABLE 50 ITALY: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 62

    TABLE 51 ITALY: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 62

    TABLE 52 SPAIN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 63

    TABLE 53 SPAIN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 63

    TABLE 54 SPAIN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 64

    TABLE 55 REST OF WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 64

    TABLE 56 REST OF WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 65

    TABLE 57 REST OF WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 65

    TABLE 58 EASTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 66

    TABLE 59 EASTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 66

    TABLE 60 EASTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 67

    TABLE 61 ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 68

    TABLE 62 ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 69

    TABLE 63 ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 69

    TABLE 64 ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 70

    TABLE 65 JAPAN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 70

    TABLE 66 JAPAN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 71

    TABLE 67 JAPAN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 71

    TABLE 68 CHINA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 72

    TABLE 69 CHINA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 72

    TABLE 70 CHINA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 73

    TABLE 71 INDIA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 73

    TABLE 72 INDIA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 74

    TABLE 73 INDIA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 74

    TABLE 74 AUSTRALIA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 75

    TABLE 75 AUSTRALIA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 75

    TABLE 76 AUSTRALIA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 76

    TABLE 77 SOUTH KOREA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 76

    TABLE 78 SOUTH KOREA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 77

    TABLE 79 SOUTH KOREA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 77

    TABLE 80 REST OF ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 78

    TABLE 81 REST OF ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 78

    TABLE 82 REST OF ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 79

    TABLE 83 MIDDLE EAST & AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 80

    TABLE 84 MIDDLE EAST & AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 81

    TABLE 85 MIDDLE EAST & AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 81

    TABLE 86 MIDDLE EAST & AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 82

    TABLE 87 MIDDLE EAST: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 82

    TABLE 88 MIDDLE EAST: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 83

    TABLE 89 MIDDLE EAST: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 83

    TABLE 90 AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 84

    TABLE 91 AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 TO 2027 (USD MILLION) 84

    TABLE 92 AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 85


    14 List of Figures

    FIGURE 1 MARKET SYNOPSIS 14

    FIGURE 2 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: STRUCTURE 16

    FIGURE 3 RESEARCH PROCESS 17

    FIGURE 4 TOP-DOWN AND BOTTOM-UP APPROACHES 20

    FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET 21

    FIGURE 6 PORTER’S FIVE FORCES MODEL 24

    FIGURE 7 VALUE CHAIN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET 26

    FIGURE 8 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY PRODUCT TYPE, 2020 (%) 28

    FIGURE 9 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2020 & 2027 29

    FIGURE 10 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY SERVICES, 2020 (%) 32

    FIGURE 11 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2020 & 2027 33

    FIGURE 12 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY END USER, 2020 (%) 36

    FIGURE 13 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2020 & 2027 37

    FIGURE 14 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY REGION, 2020 (%) 40

    FIGURE 15 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION, 2020 & 2027 40

    FIGURE 16 AMERICAS: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY REGION, 2020 (%) 42

    FIGURE 17 NORTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY COUNTRY, 2020 (%) 45

    FIGURE 18 EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY REGION, 2020 (%) 52

    FIGURE 19 WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY COUNTRY/REGION, 2020 (%) 55

    FIGURE 20 ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY COUNTRY/REGION, 2020 (%) 68

    FIGURE 21 MIDDLE EAST & AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY REGION, 2020 (%) 80

    FIGURE 22 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, COMPANY SHARE ANALYSIS, 2020 (%) 86



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.